Skip to nav Skip to content
Jung  Choi

Jung Choi, MD, PhD

Program: Diagnostic Imaging and Interventional Radiology

Contact

  • Overview

    Dr. Choi’s research interests are focused in gastrointestinal and genitourinary imaging, including projects in molecular imaging and radiomics.

    Associations

    • Diagnostic Imaging and Interventional Radiology
    • Cancer Imaging & Technology Center of Excellence

    Education & Training

    Graduate:

    • UCLA Crump Institute for Molecular Imaging, Postdoctoral Fellow - Research Fellowship
    • New York University, PhD - Molecular Oncology and Immunology
    • UCLA Department of Radiology Division of Medical Imaging Informatics, Postdoctoral Fellow - Research Fellowship

    Internship:

    • UCLA Medical Center - Intern - Internal Medicine

    Board Certification:

      Fellowship:

      • Stanford University Medical Center - Body Imaging Radiology Fellowship

      Residency:

      • UCLA School of Medicine - Radiological Sciences

      Medical School:

      • New York University - MD
    • Research Interest

      My research interests include molecular imaging with regards to cancer detection. I am currently collaborating with the Gillies research group and am interested in identifying cancer specific markers for imaging in the preclinical and clinical stage, including using hyperpolarized compounds for detecting tumor activity with MR spectroscopy.  

    • Publications

      • Choi JW, Dean EA, Lu H, Thompson Z, Qi J, Krivenko G, Jain MD, Locke FL, Balagurunathan Y. Repeatability of metabolic tumor burden and lesion glycolysis between clinical readers. Front Immunol. 2023 Feb.14:994520. Pubmedid: 36875072. Pmcid: PMC9975754.
      • Zhang J, Gallaher J, Cunningham JJ, Choi JW, Ionescu F, Chatwal MS, Jain R, Kim Y, Wang L, Brown JS, Anderson AR, Gatenby RA. A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer. Cancers (Basel). 2022 Oct.14(21). Pubmedid: 36358643. Pmcid: PMC9656891.
      • Wang S, Budzevich M, Abdalah MA, Balagurunathan Y, Choi JW. In Vivo Imaging of Rat Vascularity with FDG-Labeled Erythrocytes. Pharmaceuticals (Basel). 2022 Feb.15(3). Pubmedid: 35337090. Pmcid: PMC8953049.
      • Permuth JB, Vyas S, Li J, Chen DT, Jeong D, Choi JW. Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas. Front Oncol. 2021 Jul.11:712950. Pubmedid: 34367997. Pmcid: PMC8339963.
      • Permuth JB, Dezsi KB, Vyas S, Ali KN, Basinski TL, Utuama OA, Denbo JW, Klapman J, Dam A, Carballido E, Kim DW, Pimiento JM, Powers BD, Otto AK, Choi JW, Chen DT, Teer JK, Beato F, Ward A, Cortizas EM, Whisner SY, Williams IE, Riner AN, Tardif K, Velanovich V, Karachristos A, Douglas WG, Legaspi A, Allan BJ, Meredith K, Molina-Vega MA, Bao P, St Julien J, Huguet KL, Green L, Odedina FT, Kumar NB, Simmons VN, George TJ, Vadaparampil ST, Hodul PJ, Arnoletti JP, Awad ZT, Bose D, Jiang K, Centeno BA, Gwede CK, Malafa M, Judge SM, Judge AR, Jeong D, Bloomston M, Merchant NB, Fleming JB, Trevino JG. The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer. Cancers (Basel). 2021 Feb.13(4). Pubmedid: 33671939. Pmcid: PMC7919015.
      • Lu H, Parra NA, Qi J, Gage K, Li Q, Fan S, Feuerlein S, Pow-Sang J, Gillies R, Choi JW, Balagurunathan Y. Repeatability of Quantitative Imaging Features in Prostate Magnetic Resonance Imaging. Front Oncol. 2020 May.10:551. Pubmedid: 32457827. Pmcid: PMC7221156.
      • El-Kenawi A, Gatenbee C, Robertson-Tessi M, Bravo R, Dhillon J, Balagurunathan Y, Berglund A, Vishvakarma N, Ibrahim-Hashim A, Choi J, Luddy K, Gatenby R, Pilon-Thomas S, Anderson A, Ruffell B, Gillies R. Correction: Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer. Brit J Cancer. 2020 Mar.122(7):1118. Pubmedid: 31937927. Pmcid: PMC7109119.
      • Polk SL, Choi JW, McGettigan MJ, Rose T, Ahmed A, Kim J, Jiang K, Balagurunathan Y, Qi J, Farah PT, Rathi A, Permuth JB, Jeong D. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy. World J Gastroenterol. 2020 Jun.26(24):3458-3471. Pubmedid: 32655269. Pmcid: PMC7327792.
      • Wang S, Choi JW. Imaging the Vasculature of Immunodeficient Mice Using Positron Emission Tomography/computed Tomography (PET/CT) and 18F-fluorodeoxyglucose Labeled Human Erythrocytes. Bio Protoc. 2019 Oct.9(19):e3391. Pubmedid: 33654883. Pmcid: PMC7920323.
      • El-Kenawi A, Gatenbee C, Robertson-Tessi M, Bravo R, Dhillon J, Balagurunathan Y, Berglund A, Visvakarma N, Ibrahim-Hashim A, Choi J, Luddy K, Gatenby R, Pilon-Thomas S, Anderson A, Ruffell B, Gillies R. Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer. Brit J Cancer. 2019 Oct.121(7):556-566. Pubmedid: 31417189. Pmcid: PMC6889319.
      • Parra NA, Lu H, Li Q, Stoyanova R, Pollack A, Punnen S, Choi J, Abdalah M, Lopez C, Gage K, Park JY, Kosj Y, Pow-Sang JM, Gillies RJ, Balagurunathan Y. Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors. Oncotarget. 2019 Mar.10(21):2113. Pubmedid: 31007853. Pmcid: PMC6459347.
      • Parra NA, Lu H, Choi J, Gage K, Pow-Sang J, Gillies RJ, Balagurunathan Y. Habitats in DCE-MRI to Predict Clinically Significant Prostate Cancers. Tomography. 2019 Mar.5(1):68-76. Pubmedid: 30854444. Pmcid: PMC6403034.
      • Permuth JB, Clark Daly A, Jeong D, Choi JW, Cameron ME, Chen DT, Teer JK, Barnett TE, Li J, Powers BD, Kumar NB, George TJ, Ali KN, Huynh T, Vyas S, Gwede CK, Simmons VN, Hodul PJ, Carballido EM, Judge AR, Fleming JB, Merchant N, Trevino JG. Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities. Cancer Med. 2019 Jun.8(6):3314-3324. Pubmedid: 31074202. Pmcid: PMC6558500.
      • Choi JW, Budzevich M, Wang S, Gage K, Estrella V, Gillies RJ. In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes. PLoS One. 2019 Jan.14(1):e0211012. Pubmedid: 30682160. Pmcid: PMC6347438.
      • Li Q, Lu H, Choi J, Gage K, Feuerlein S, Pow-Sang JM, Gillies R, Balagurunathan Y. Radiological semantics discriminate clinically significant grade prostate cancer. Cancer Imaging. 2019 Dec.19(1):81. Pubmedid: 31796094. Pmcid: PMC6889697.
      • Parra AN, Lu H, Li Q, Stoyanova R, Pollack A, Punnen S, Choi J, Abdalah M, Lopez C, Gage K, Park JY, Kosj Y, Pow-Sang JM, Gillies RJ, Balagurunathan Y. Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors. Oncotarget. 2018 Dec.9(98):37125-37136. Pubmedid: 30647849. Pmcid: PMC6324677.
      • Permuth JB, Chen DT, Yoder SJ, Li J, Smith AT, Choi JW, Kim J, Balagurunathan Y, Jiang K, Coppola D, Centeno BA, Klapman J, Hodul P, Karreth FA, Trevino JG, Merchant N, Magliocco A, Malafa MP, Gillies R. Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas. Sci Rep. 2017 Sep.7(1):10484. Pubmedid: 28874676. Pmcid: PMC5585319.
      • Permuth JB, Choi JW, Chen DT, Jiang K, DeNicola G, Li JN, Coppola D, Centeno BA, Magliocco A, Balagurunathan Y, Merchant N, Trevino JG, Jeong D. A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?. Cancer Biol Med. 2017 Feb.14(1):66-73. Pubmedid: 28443205. Pmcid: PMC5365183.
      • Jeong D, Choi JW, Jeong K, Sokol L. CT findings associated with blastic plasmacytoid dendritic cell neoplasm: a case report. Acta Radiol Open. 2016 Jul.5(7):2058460116657688. Pubmedid: 27504192. Pmcid: PMC4963986.
      • Permuth JB, Choi J, Balarunathan Y, Kim J, Chen DT, Chen L, Orcutt S, Doepker MP, Gage K, Zhang G, Latifi K, Hoffe S, Jiang K, Coppola D, Centeno BA, Magliocco A, Li Q, Trevino J, Merchant N, Gillies R, Malafa M, On Behalf Of The Florida Pancreas Collaborative . Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms. Oncotarget. 2016 Dec.7(52):85785-85797. Pubmedid: 27589689. Pmcid: PMC5349874.
      • Rose T, Choi J. Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know. Am J Med. 2015 Sep.128(9):943-949. Pubmedid: 25820169.
      • Kuppler K, Jeong D, Choi JW. Non-infectious cholecystopathy secondary to high-dose IL-2 cancer immunotherapy. Acta Radiol Open. 2015 Oct.4(10):2058460115579458. Pubmedid: 26576289. Pmcid: PMC4641551.
      • Jeong D, Malalis C, Arrington JA, Field AS, Choi JW, Kocak M. Mean apparent diffusion coefficient values in defining radiotherapy planning target volumes in glioblastoma. Quant Imaging Med Surg. 2015 Dec.5(6):835-845. Pubmedid: 26807366. Pmcid: PMC4700247.
      • Abrahams D, Jeune-Smith Y, Bode A, Baldwin M, Choi JW. Real-time ultrasound-guided needle injection of the mouse jugular vein. Curr Protoc Mouse Biol. 2014 Sep.4(3):141-150. Pubmedid: 25723964.
      • Nimgaonkar A, Choi JW, Nguyen L, Triadafilopoulos G. Gastrointestinal dysmotility. Digest Dis Sci. 2012 May.57(5):1130-1133. Pubmedid: 22038542.
      • Hasegawa S, Choi JW, Rao J. Single-cell detection of trans-splicing ribozyme in vivo activity. J Am Chem Soc. 2004 Jun.126(23):7158-7159. Pubmedid: 15186136.
      • Choi JW, Pampeno C, Vukmanovic S, Meruelo D. Characterization of the transcriptional expression of Notch-1 signaling pathway members, Deltex and HES-1, in developing mouse thymocytes. Dev Comp Immunol. 2002 Jul.26(6):575-588. Pubmedid: 12031417.
      • Pampeno CL, Vallerie AM, Choi J, Meruelo NC, Meruelo D. Genomic analysis and localization of murine Deltex, a modulator of notch activity, to mouse chromosome 5 and its human homolog to chromosome 12. DNA Cell Biol. 2001 Mar.20(3):141-148. Pubmedid: 11313017.
      • Yu A, Choi J, Ohno K, Levin B, Rom WN, Meruelo D. Specific cell targeting for delivery of toxins into small-cell lung cancer using a streptavidin fusion protein complex. DNA Cell Biol. 2000 Jul.19(7):383-388. Pubmedid: 10945228.
      • Zebala JA, Choi J, Barany F. Characterization of steady state, single-turnover, and binding kinetics of the TaqI restriction endonuclease. J Biol Chem. 1992 Apr.267(12):8097-8105. Pubmedid: 1569066.
      • Zebala JA, Choi J, Trainor GL, Barany F. DNA recognition of base analogue and chemically modified substrates by the TaqI restriction endonuclease. J Biol Chem. 1992 Apr.267(12):8106-8116. Pubmedid: 1569067.

    Find a Researcher Search